Diagnostics & Healthcare News
Owlet Announces FDA-Clearance of the First Prescription Pulse Oximetry Sock for Infants
Owlet (NYSE: OWLT, “the Company”), the pioneer of smart baby monitoring, announces clearance from the U.S. Food and Drug Administration (“FDA”) of BabySat™, the first medical pulse-oximetry device featuring its advanced, wire-free sock design. Owlet is a leader in infant...